0.8736
price down icon8.24%   -0.0784
after-market Handel nachbörslich: .89 0.0164 +1.88%
loading

Enlivex Ltd Aktie (ENLV) Neueste Nachrichten

pulisher
Apr 04, 2026

ENLV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026
pulisher
Apr 03, 2026

ENLV PE Ratio & Valuation, Is ENLV Overvalued - Intellectia AI

Apr 03, 2026
pulisher
Apr 01, 2026

Enlivex clears pivotal FDA hurdle in knee osteoarthritis - Longevity.Technology

Apr 01, 2026
pulisher
Apr 01, 2026

Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index

Apr 01, 2026
pulisher
Apr 01, 2026

Market Wrap: What analysts say about Enlivex Therapeutics Ltd stock2026 Big Picture & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 01, 2026
pulisher
Mar 31, 2026

Enlivex shares jump after earnings as treasury gains boost results - MSN

Mar 31, 2026
pulisher
Mar 28, 2026

Enlivex Therapeutics (NASDAQ:ENLV) Stock Rating Lowered by Wall Street Zen - marketbeat.com

Mar 28, 2026
pulisher
Mar 27, 2026

Enlivex Announces $21M Debt Financing and Prediction Markets Treasury Expansion - Bitcoin.com News

Mar 27, 2026
pulisher
Mar 27, 2026

RAIN Token Climbs to 25th in Market Cap Following Institutional Activity and Protocol Upgrades - Bitget

Mar 27, 2026
pulisher
Mar 26, 2026

Enlivex Therapeutics Tokenized Stock (Ondo) price today, ENLVon to USD live price, marketcap and chart - CoinMarketCap

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 - NewMediaWire

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Posts $1.23B Profit (Net Income) For Fiscal 2025 | Corporate - EQS News

Mar 26, 2026
pulisher
Mar 26, 2026

Published on: 2026-03-26 22:45:56 - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Reports Full-Year 2025 Results, Profit of $1.23 Billion and Diluted Earnings per Share of $25.48 - marketscreener.com

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Posts $1.23 Billion Profit for 2025 on Treasury Asset Gains - The Globe and Mail

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets - tipranks.com

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt - manilatimes.net

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex (NASDAQ: ENLV) highlights Rain AI launch, $5M grants and RAIN token burn - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

One prompt can now create a live prediction market as Rain adds $5M - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Enlivex Obtains $21 Million Loan to Purchase RAIN Tokens and Initiate $20 Million Buyback - Bitget

Mar 26, 2026
pulisher
Mar 25, 2026

Earnings call transcript: Enlivex Q4 2025 sees stock surge on treasury gains - Investing.com Australia

Mar 25, 2026
pulisher
Mar 25, 2026

Envilex Therapeutics (ENLV) Reports Strong FY GAAP EPS - GuruFocus

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Soars After FDA Approval for Allocetra Trial - StocksToTrade

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Stock Boosted by FDA Approval for Allocetra in Osteoarthritis Trials - timothysykes.com

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Therapeutics Q4 Earnings Call Highlights - marketbeat.com

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Allocetra Takes A Leap as FDA Clears Phase 2b Trial for Osteoarthritis - timothysykes.com

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 - Bitget

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Secures $21 Million Convertible Debt, Expands RAIN Token Holdings and Launches $20 Million Buyback - The Globe and Mail

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Therapeutics (NASDAQ:ENLV) Releases Earnings Results, Beats Estimates By $12.88 EPS - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Ltd. Reports $1.23 Billion Net Income for 2025 Driven by Treasury Asset Appreciation - Quiver Quantitative

Mar 25, 2026
pulisher
Mar 25, 2026

Biotech–crypto hybrid Enlivex (NASDAQ: ENLV) outlines RAIN treasury risks and funding needs - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted ... - Bluefield Daily Telegraph

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex (NASDAQ: ENLV) nets $1.23B in 2025 on digital treasury gains - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Treasury gains push Enlivex to $1.23B profit, $2.31B in assets - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex secures $21M debt financing, buys more RAIN tokens By Investing.com - Investing.com Australia

Mar 25, 2026
pulisher
Mar 25, 2026

Strategic Move: Enlivex Allocates $21 Million for RAIN Token Acquisition Amid Share Buyback - MEXC

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Raises $21 Million to Expand RAIN Token Treasury Holdings - Blockonomi

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Raises $21M to Expand RAIN Token Treasury and Biotechnology Pipeline - MoneyCheck

Mar 25, 2026
pulisher
Mar 25, 2026

Enlivex Secures $21M Funding to Boost RAIN Treasury Strategy - CoinCentral

Mar 25, 2026
pulisher
Mar 24, 2026

Off The Hook Yachts and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Mar 24, 2026
pulisher
Mar 24, 2026

Enlivex stock rating held at Hold by D. Boral Capital after debt deal - Investing.com Australia

Mar 24, 2026
pulisher
Mar 24, 2026

Enlivex Funding Rounds, Token Sale Review & Tokenomics Analysis - CryptoRank

Mar 24, 2026
pulisher
Mar 24, 2026

Enlivex secures $21M debt financing, buys more RAIN tokens - Investing.com

Mar 24, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):